RxDoctor Payments Data

Carla Schlenke

Psychiatric/Mental Health · Orange Park, FLNPI 1720101892

Payments from drug & device makers

$2,747in general payments, 2019–2025

Across 137 payments — averaging $20.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$862
  • Alkermes, Inc.$264
  • Otsuka America Pharmaceutical, Inc.$260
  • Lundbeck LLC$233
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$218
  • Teva Pharmaceuticals USA, Inc.$188
  • plus $723 from 13 others

What the payments were for

  • Food & beverage$2,747100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,747 in reported general payments places this provider in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

See all psychiatric/mental health providers in Florida

Medicare billing

Part B allowed, 2024
$21,210
Medicare patients
46
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl19$26,373
RexultiBrexpiprazole14$24,089
Aripiprazole51$2,446
Olanzapine125$2,369
Chlorpromazine Hcl12$1,640
Quetiapine Fumarate87$990
Buspirone Hcl32$874
Mirtazapine50$831
Trazodone Hcl110$795
Clonazepam138$765
Duloxetine Hcl44$753
Prazosin Hcl49$739
Lamotrigine61$714
Clozapine24$561
Divalproex Sodium23$473

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$862$26,37319 claims
Otsuka America Pharmaceutical, Inc.Rexulti$260$24,08914 claims
Lilly USA, LLCOlanzapine$24$2,369125 claims
Almatica Pharma LLCSertraline Hcl$106$29068 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,096 psychiatric/mental health providers in Florida.

Other psychiatric/mental health in Orange Park

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →